Plexin-A4 is a member of the plexin family, which are transmembrane receptors known to mediate various cellular responses to semaphorins, a large family of secreted or membrane-bound proteins. Plexins are characterized by their roles in the regulation of cell movement and guidance, impacting processes such as cell migration, proliferation, and cytoskeletal dynamics. Plexin-A4, in particular, engages in intricate intracellular signaling once it binds to its semaphorin ligands. Activators of Plexin-A4 are chemical entities that can enhance the activity of this receptor, either by increasing its affinity for its ligands or by facilitating its downstream signaling processes. The activation of Plexin-A4 can influence the behavior of cells expressing this receptor, affecting their responses to external cues provided by semaphorins. The exact mechanisms by which these activators function can be complex, potentially involving alterations in receptor conformation, promoting receptor dimerization or oligomerization, or enhancing receptor-ligand interactions.
Plexin-A4 activators are specialized molecules that may mimic the action of natural ligands or alternatively modify the receptor to increase its activity. These activators can be designed following an understanding of the molecular structures involved in Plexin-A4 signaling pathways. The structural domains of Plexin-A4 are critical for its interaction with semaphorins, and activators may target these domains to exert their effects. Such domains include the sema domain, which is responsible for ligand binding, and the intracellular kinase-like and GTPase-activating protein (GAP) domains, which are involved in signal transduction. The development of Plexin-A4 activators would thus rely on the detailed knowledge of these protein-protein interactions and the specific intracellular signaling cascades that are initiated upon receptor activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits protein synthesis, can indirectly activate PLXNA4 by suppression of repressive proteins. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, can indirectly influence PLXNA4 through cAMP-dependent pathways. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $41.00 $77.00 $153.00 | ||
Hormone that can influence a wide range of cellular processes, indirectly impacting PLXNA4 activity. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
Inhibits BMP signaling, potentially leading to indirect PLXNA4 activation. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Wnt/β-catenin pathway activator, potentially leading to indirect PLXNA4 activation. | ||||||
Epz004777 | 1338466-77-5 | sc-507560 | 100 mg | $575.00 | ||
Inhibits DOT1L methyltransferase, potentially leading to indirect PLXNA4 activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Can influence cellular differentiation and growth, potentially impacting PLXNA4 activity. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $58.00 $188.00 $884.00 | 10 | |
GSK-3 inhibitor, can indirectly activate PLXNA4 through Wnt/β-catenin pathway activation. | ||||||
Pyrvinium Pamoate | 3546-41-6 | sc-476920A sc-476920 | 250 mg 500 mg | $228.00 $422.00 | ||
Wnt pathway inhibitor, can indirectly influence PLXNA4 activity. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-beta signaling, potentially leading to indirect PLXNA4 activation. | ||||||